GLENMARK PHARMA
With the strong recovery of the pharma sector, Glenmark is at the pre-virus levels and has been attempting to breakout of the range. The sector has been in consolidation for several days and it may attempt a breakout to slightly higher levels. The pharma sector may not face sell offs in the midst of the pandemic, in my opinion.
Trade closed: target reached
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.